Alexandre Fraichard (genOway (Group))

Fraichard, Alexandre (genOway 200610 CEO + Co-Founder)

	Organisation	genOway (Group)
	Product	transgenic animal technology
	Product 2	transgenic mouse

Record changed: 2020-03-28

Picture [iito] Plain Stupid Simple 650x80px

More documents for Alexandre Fraichard

[1] genOway S.A.. (1/7/20). "Press Release: genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models". Lyon....
[2] genOway S.A.. (10/30/19). "Press Release: The Institut Pasteur and Cellectis Extend Exclusive License Rights by Granting genOway the Authority to Take Action against Infringement". Lyon & Paris....
[3] genOway S.A.. (6/4/19). "Press Release: genOway Announces the Consolidation of a Precompetitive Consortium to Develop and Validate Humanized Immune Checkpoint Mouse Models". Lyon....
[4] genOway S.A.. (5/27/19). "Press Release: genOway Licenses the Flex Technology Rights to HHMI for the Distribution of Its AAV FLEX". Lyon....
[5] Merck KGaA. (12/10/18). "Press Release: Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models". Darmstadt....
[6] genOway S.A.. (9/25/18). "Press Release: genOway Announces the Acquisition of Axenis to Create the Largest Offer of Preclinical Models in the Immuno-oncology and Immuno-inflammation Space". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

Alexandre Fraichard (genOway (Group))

More documents for Alexandre Fraichard